Download PDF
Neuropediatrics 2014; 45(05): 309-313
DOI: 10.1055/s-0034-1378129
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Granzyme B Gene Polymorphism Associated with Subacute Sclerosing Panencephalitis

Sibel P. Yentur
1   Department of Physiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
,
Hatice Nur Aydin
1   Department of Physiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
,
Candan Gurses
2   Department of Neurology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
,
Veysi Demirbilek
3   Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
,
Umit Kuru
4   Department of Pediatrics, Bayrampaşa Hospital, Istanbul, Turkey
,
Serap Uysal
5   Department of Pediatrics, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
,
Zuhal Yapici
2   Department of Neurology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
,
Safa Baris
6   Department of Pediatrics, Marmara School of Medicine, Istanbul, Turkey
,
Gülden Yilmaz
7   Department of Microbiology, Istanbul Medical Faculty, Istanbul, Turkey
,
Ozlem Cokar
8   Department of Neurology, Haseki Hospital, Istanbul, Turkey
,
Emel Onal
9   Department of Public Health, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
,
Ayşen Gokyigit
2   Department of Neurology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
,
Güher Saruhan-Direskeneli
1   Department of Physiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
› Author Affiliations
Further Information

Publication History

17 December 2013

30 March 2014

Publication Date:
29 May 2014 (online)

    Permissions and Reprints

Abstract

Background Subacute sclerosing panencephalitis (SSPE) is a late complication of measles infection. Immune dysfunction related to genetic susceptibility has been considered in disease pathogenesis. A functional single nucleotide polymorphism (SNP) of granzyme B gene (GZMB) reported in several pathologies may also be involved in susceptibility to SSPE.

Patients and Methods An SNP (rs8192917, G → A, R→Q) was screened in 118 SSPE patients and 221 healthy controls (HC) by polymerase chain reaction-restriction fragment length polymorphism. Frequencies were compared between groups. In vitro production of GZMB was measured in controls with different genotypes.

Results The SNP had a minor allele (G) frequency of 0.22 in patients and 0.31 in controls. GG genotype was significantly less frequent in patients (odds ratio, 0.23). G allele carriers produced relatively higher levels of GZMB, when stimulated in vitro.

Conclusion These findings implicate possible effect of this genetic polymorphism in susceptibility to SSPE which needs to be confirmed in bigger populations.

Keywords

subacute sclerosing panencephalitis - granzyme B - single nucleotide polymorphism - function
 

  • References

  • 1 Baczko K, Lampe J, Liebert UG , et al. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993; 197 (1) 188-195
    CrossrefPubMedGoogle Scholar
  • 2 Breschkin AM, Morgan EM, McKimm J, Rapp F. SSPE-BIKEN: a naturally arising hemagglutination-defective mutant of measles virus. J Med Virol 1979; 4 (1) 67-80
    CrossrefPubMedGoogle Scholar
  • 3 Cattaneo R, Schmid A, Spielhofer P , et al. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 1989; 173 (2) 415-425
    CrossrefPubMedGoogle Scholar
  • 4 Dyken PR. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev 2001; 7 (3) 217-225
    CrossrefPubMedGoogle Scholar
  • 5 Graves MC. Subacute sclerosing panencephalitis. Neurol Clin 1984; 2 (2) 267-280
    PubMedGoogle Scholar
  • 6 Schneider-Schaulies J, Meulen Vt, Schneider-Schaulies S. Measles infection of the central nervous system. J Neurovirol 2003; 9 (2) 247-252
    CrossrefPubMedGoogle Scholar
  • 7 Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S. Measles virus interactions with cellular receptors: consequences for viral pathogenesis. J Neurovirol 2001; 7 (5) 391-399
    CrossrefPubMedGoogle Scholar
  • 8 van Els CA, Nanan R. T cell responses in acute measles. Viral Immunol 2002; 15 (3) 435-450
    CrossrefPubMedGoogle Scholar
  • 9 Dhib-Jalbut S, Jacobson S, McFarlin DE, McFarland HF. Impaired measles-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann N Y Acad Sci 1988; 540: 645-648
    CrossrefPubMedGoogle Scholar
  • 10 Yentür SP, Gürses C, Demirbilek V , et al. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 2005; 170 (1-2) 179-185
    CrossrefPubMedGoogle Scholar
  • 11 Hara T, Yamashita S, Aiba H , et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000; 6 (2) 121-126
    CrossrefPubMedGoogle Scholar
  • 12 Inoue T, Kira R, Nakao F , et al. Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 2002; 59 (5) 822-827
    CrossrefPubMedGoogle Scholar
  • 13 Torisu H, Kusuhara K, Kira R , et al. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 2004; 62 (3) 457-460
    CrossrefPubMedGoogle Scholar
  • 14 Ishizaki Y, Takemoto M, Kira R , et al. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J Neurovirol 2008; 14 (6) 486-491
    CrossrefPubMedGoogle Scholar
  • 15 Ishizaki Y, Yukaya N, Kusuhara K , et al. PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis. Hum Genet 2010; 127 (4) 411-419
    CrossrefPubMedGoogle Scholar
  • 16 Piskin IE, Calık M, Abuhandan M, Kolsal E, Celik SK, Iscan A. PD-1 gene polymorphism in children with subacute sclerosing panencephalitis. Neuropediatrics 2013; 44 (4) 187-190
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Piskin IE, Karakas-Celik S, Calik M , et al. Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis. DNA Cell Biol 2013; 32 (6) 336-340
    CrossrefPubMedGoogle Scholar
  • 18 McIlroy D, Cartron PF, Tuffery P , et al. A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc Natl Acad Sci U S A 2003; 100 (5) 2562-2567
    CrossrefPubMedGoogle Scholar
  • 19 Sun J, Bird CH, Thia KY, Matthews AY, Trapani JA, Bird PI. Granzyme B encoded by the commonly occurring human RAH allele retains pro-apoptotic activity. J Biol Chem 2004; 279 (17) 16907-16911
    CrossrefPubMedGoogle Scholar
  • 20 Girnita DM, Webber SA, Brooks MM , et al. Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms. Transplantation 2009; 87 (12) 1801-1806
    CrossrefPubMedGoogle Scholar
  • 21 Corrales-Tellez E, Vu D, Shah T, Hutchinson I, Min DI. Association between granzyme B and perforin I polymorphisms and allograft outcomes in Hispanic kidney transplant recipients. Clin Transplant 2013; 27 (3) E308-E315
    CrossrefPubMedGoogle Scholar
  • 22 Espinoza LJ, Takami A, Nakata K , et al; Japan Marrow Donor Program. Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. PLoS ONE 2011; 6 (8) e23827
    CrossrefPubMedGoogle Scholar
  • 23 Knevel R, Krabben A, Wilson AG , et al. A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis. Arthritis Rheum 2013; 65 (3) 582-589
    CrossrefPubMedGoogle Scholar
  • 24 Vuorinen T, Peri P, Vainionpää R. Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures. Eur J Clin Invest 2003; 33 (5) 434-442
    CrossrefPubMedGoogle Scholar
  • 25 Gascon GG. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996; 3 (4) 260-269
    CrossrefPubMedGoogle Scholar
  • 26 Oztürk A, Gürses C, Baykan B, Gökyigit A, Eraksoy M. Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol 2002; 17 (1) 25-29
    CrossrefPubMedGoogle Scholar
  • 27 Untergasser A, Cutcutache I, Koressaar T , et al. Primer3—new capabilities and interfaces. Nucleic Acids Res 2012; 40 (15) e115
    CrossrefPubMedGoogle Scholar
  • 28 Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421 (6921) 388-392
    CrossrefPubMedGoogle Scholar
  • 29 Onal AE, Gurses C, Direskeneli GS , et al. Subacute sclerosing panencephalitis surveillance study in Istanbul. Brain Dev 2006; 28 (3) 183-189
    CrossrefPubMedGoogle Scholar
  • 30 Nakayama T, Mori T, Yamaguchi S , et al. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res 1995; 35 (1) 1-16
    CrossrefPubMedGoogle Scholar
  • 31 Trapani JA, Sutton VR, Smyth MJ. CTL granules: evolution of vesicles essential for combating virus infections. Immunol Today 1999; 20 (8) 351-356
    CrossrefPubMedGoogle Scholar
  • 32 Kucuksezer UC, Duymaz-Tozkir J, Gül A, Saruhan-Direskeneli G. No association of granzyme B gene polymorphism with Behçet's disease. Clin Exp Rheumatol 2009; 27 (2) (Suppl. 53) S102
    PubMedGoogle Scholar